Adare Pharma encourages pediatric medications; Australian researchers developing better hydrogels;

> Adare Pharmaceuticals and Cincinnati Children's Hospital Medical Center said they are teaming up to create an Innovation Fund to optimized and reformulate medicines for children by making them easier to administer, for example. More

> Researchers at Australia's University of Wollongong are developing heat-sensitive hydrogel that contains boron nitride. "The effectiveness of these applications is highly dependent on the hydrogel's response to changes in temperature. In most cases it needs to be very fast. The problem is that the heat does not spread rapidly through the gel," lead researcher Dr. Zhenguo Huang said. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.